Cargando…

Tear Fluid Catecholamines As Biomarkers of the Parkinson’s Disease: A Clinical and Experimental Study

An important approach to an early diagnosis of Parkinson’s disease (PD) is screening for peripheral biomarkers in patients at the early clinical stage. In this study, we evaluated catecholamine concentration changes in the tear fluid of untreated PD patients as biomarkers. Norepinephrine and dopamin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, A. R., Nodel, M. R., Pavlenko, T. A., Chesnokova, N. B., Yakhno, N. N., Ugrumov, M. V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	A.I. Gordeyev 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977954/ https://www.ncbi.nlm.nih.gov/pubmed/31993241 http://dx.doi.org/10.32607/20758251-2019-11-4-99-103

Ejemplares similares

Molecular Mechanisms and Clinical Manifestations of Catecholamine Dysfunction in the Eye in Parkinson’s Disease As a Basis for Developing Early Diagnosis
por: Pavlenko, T. A., et al.
Publicado: (2020)

A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice
por: Bogdanov, Vsevolod, et al.
Publicado: (2021)

Biochemical and Functional Changes in the Eye As a Manifestation of Systemic Degeneration of the Nervous System in Parkinsonism
por: Kim, A. R., et al.
Publicado: (2018)

Searching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage
por: Katunina, Elena A., et al.
Publicado: (2023)

A Monoiodotyrosine Challenge Test in a Parkinson’s Disease Model
por: Kim, A. R., et al.
Publicado: (2021)

Cerebrospinal fluid catecholamines in delirium and dementia
por: Henjum, Kristi, et al.
Publicado: (2021)

The Impact of a Pulmonary-Artery-Catheter-Based Protocol on Fluid and Catecholamine Administration in Early Sepsis
por: Bethlehem, Carina, et al.
Publicado: (2012)

Development of early diagnosis of Parkinson's disease: Illusion or reality?
por: Ugrumov, Michael
Publicado: (2020)

Increased alpha-synuclein tear fluid levels in patients with Parkinson’s disease
por: Maass, Fabian, et al.
Publicado: (2020)

Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing
por: Bachhuber, Franziska, et al.
Publicado: (2021)

Appropriate fluid resuscitation of septic shock patients pretreated with high doses of catecholamines
por: Lewejohann, JC, et al.
Publicado: (2015)

VCP expression decrease as a biomarker of preclinical and early clinical stages of Parkinson’s disease
por: Alieva, Anelya, et al.
Publicado: (2020)

Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease
por: Henjum, Kristi, et al.
Publicado: (2022)

Tear biomarkers for keratoconus
por: Nishtala, Krishnatej, et al.
Publicado: (2016)

Experimental Analysis of Tear Fluid and Its Processing for the Diagnosis of Multiple Sclerosis
por: Tomečková, Vladimíra, et al.
Publicado: (2023)

Importance of adequate fluid resuscitation in patients with severe septic shock on high catecholamine doses
por: Lewejohann, J, et al.
Publicado: (2008)

Potential Tear Biomarkers for the Diagnosis of Parkinson’s Disease—A Pilot Study
por: Acera, Arantxa, et al.
Publicado: (2022)

Potential Biomarkers for Noninfectious Scleritis Identified by Serum and Tear Fluid Proteomics
por: Vergouwen, Daphne P.C., et al.
Publicado: (2023)

Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease
por: Isaias, Ioannis U, et al.
Publicado: (2011)

Catecholamines and Neurodegeneration in Parkinson’s Disease—From Diagnostic Marker to Aggregations of α-Synuclein
por: Sawada, Hideyuki, et al.
Publicado: (2013)

Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
por: Boyda, Heidi N., et al.
Publicado: (2020)

Excretion of catecholamines in rats, mice and chicken
por: Lepschy, M., et al.
Publicado: (2008)

Catecholamine induced cardiomyopathy in pheochromocytoma
por: Varghese, Ron Thomas, et al.
Publicado: (2013)

Activity-dependent constraints on catecholamine signaling
por: Li, Li, et al.
Publicado: (2023)

INVOLVEMENT OF CATECHOLAMINES IN THE MYOCARDIUM OF RATS SUBMITTED TO EXPERIMENTAL MODEL OF PORTAL HYPERTENSION
por: VINHOLI, Antonella, et al.
Publicado: (2018)

The Clinical Characteristics of Pheochromocytomas and Paragangliomas with Negative Catecholamines
por: Zhao, Lin, et al.
Publicado: (2022)

Experimental Subarachnoid Hemorrhage Drives Catecholamine-Dependent Cardiac and Peripheral Microvascular Dysfunction
por: Dinh, Danny D., et al.
Publicado: (2020)

Management of an acute catecholamine-induced cardiomyopathy and circulatory collapse: a multidisciplinary approach
por: Casey, R T, et al.
Publicado: (2017)

The role of DJ-1 complexes and catecholamine metabolism: relevance for familial and idiopathic Parkinson’s disease
por: Piston, Dominik, et al.
Publicado: (2018)

Serotonin versus catecholamine deficiency: behavioral and neural effects of experimental depletion in remitted depression
por: Homan, P, et al.
Publicado: (2015)

Catecholamine-induced cardiomyopathy and multiple organ failure in pheochromocytoma
por: Thekekara, Joel, et al.
Publicado: (2020)

What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?
por: Kim, Dana, et al.
Publicado: (2014)

Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines()
por: López-Gómez, Javier, et al.
Publicado: (2016)

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Marques, Tainá M., et al.
Publicado: (2021)

Fluid and Biopsy Based Biomarkers in Parkinson’s Disease
por: Coughlin, David G., et al.
Publicado: (2023)

Potential Biomarkers of the Earliest Clinical Stages of Parkinson's Disease
por: Alieva, Anelya Kh., et al.
Publicado: (2015)

PREDICTORS OF PLASMA AND URINARY CATECHOLAMINE LEVELS IN NORMOTENSIVE AND HYPERTENSIVE MEN AND WOMEN
por: Saxena, Aditi R., et al.
Publicado: (2013)

Analysis of tear fluid proteins: use of multiplex assays in profiling biomarkers of dry eye disease
por: Hagan, Suzanne, et al.
Publicado: (2014)

Analysis of tear fluid proteins: use of multiplex assays in profiling biomarkers of dry eye disease
por: Hagan, Suzanne, et al.
Publicado: (2014)

Tear fluid and complement activation products in tears after ocular surgery
por: Maehara, Hiroki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9plmmnh7q21ab6qtgggn2rohnq